Hydrobromides
- (1)
- (2)
- (2)
- (1)
- (5)
- (2)
- (2)
- (4)
- (3)
- (1)
- (7)
- (2)
- (2)
- (5)
- (2)
- (2)
- (2)
- (6)
- (3)
- (7)
- (2)
- (3)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (1)
- (1)
- (2)
- (15)
- (3)
- (2)
- (9)
- (1)
- (1)
- (17)
- (1)
- (3)
- (4)
- (22)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (7)
- (2)
- (14)
- (1)
- (2)
- (2)
- (2)
- (14)
- (24)
- (2)
- (2)
- (2)
- (31)
- (3)
- (3)
- (4)
- (4)
Filtered Search Results
Medchemexpress LLC Arecoline hydrobromide | 300-08-3 | 99.95% | 500 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Arecoline hydrobromide is a naturally occurring, brain-penetrant, and orally active psychoactive alkaloid. It functions as a partial agonist for both nicotinic and muscarinic acetylcholine receptors, influencing various neurological processes. This compound has been noted for its ability to induce stimulation, alertness, anxiolysis, and anti-parasitic effects, though it can also cause oxidative stress.
- Naturally occurring psychoactive alkaloid
- Brain-penetrant and orally active
- Acts as a partial agonist of nicotinic and muscarinic acetylcholine receptors
- Can induce stimulation, alertness, anxiolysis, and anti-parasitic effects
- Induces reactive oxygen species and cell cycle arrest in HaCaT cells
- Alleviates anxiety and depression in CFA-induced mice
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC SCH-202676 hydrobromide | 265980-25-4 | 96.81% | 348.26 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
SCH-202676 hydrobromide is an allosteric modulator of G protein-coupled receptors (GPCRs) and adenosine receptor (AR). It exhibits antiviral activity and inhibits 3CLpro in a time-dependent manner with an IC50 value of 0.655 μM.
- Allosteric modulator of G protein-coupled receptors and adenosine receptor.
- Exhibits antiviral activity.
- Inhibits 3CLpro in a time-dependent manner.
- IC50 value of 0.655 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Halofuginone (hydrobromide) | 64924-67-0 | 495.59 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Halofuginone hydrobromide (RU-19110 hydrobromide), a Febrifugine derivative, acts as a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. It specifically inhibits type-I collagen synthesis and reduces osteoarthritis (OA) by inhibiting TGF-β activity. Additionally, it functions as a potent pulmonary vasodilator through the activation of Kv channels and the blocking of voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Competitive prolyl-tRNA synthetase inhibitor (Ki of 18.3 nM)
- Inhibits type-I collagen synthesis
- Reduces osteoarthritis (OA) by inhibiting TGF-β activity
- Potent pulmonary vasodilator through Kv channel activation
- Blocks voltage-gated, receptor-operated, and store-operated Ca2+ channels
- Exhibits anti-malaria, anti-inflammatory, anti-cancer, and anti-fibrosis effects
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Remodelin (hydrobromide) | 1622921-15-6 | 99.6% | 363.28 | 500 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Remodelin hydrobromide is an orally active and selective inhibitor of acetyltransferase NAT10. It inhibits NAT10 activity, slows DNA replication, and suppresses the growth of prostate cancer cells. It also inhibits the growth of prostate cancer and hepatocellular carcinoma in xenograft models. Additionally, it enhances the healthspan in a Hutchinson-Gilford Progeria Syndrome (HGPS) mouse model.
- Orally active and selective inhibitor of acetyltransferase NAT10.
- Inhibits NAT10 activity.
- Slows DNA replication.
- Suppresses growth of prostate cancer cells.
- Inhibits the growth of prostate cancer and hepatocellular carcinoma in xenograft model.
- Enhances healthspan in Hutchinson-Gilford Progeria Syndrome (HGPS) mouse model.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 62595-74-8 | 3-bromopiperidine-2,6-dione | Abosyn Chemicals Inc. | MFCD11053059 | 192.012 | C5H6BrNO2 | 0.000 | BrC1CCC(=O)NC1=O | 5g | 812065078
3-bromopiperidine-2,6-dione | Abosyn Chemicals Inc. | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 0.000 | BrC1CCC(=O)NC1=O | 5g | 812065078
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 62595-74-8 | 3-Bromopiperidine-2,6-dione | Synthonix | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 100g | 831793878
3-Bromopiperidine-2,6-dione | Synthonix | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 100g | 831793878
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Halofuginone hydrobromide (RU-19110 hydrobromide) is a competitive prolyl-tRNA synthetase inhibitor. This Febrifugine derivative acts as a specific inhibitor of type-I collagen synthesis and helps in attenuating osteoarthritis by inhibiting TGF-β activity. It also functions as a potent pulmonary vasodilator through the activation of Kv channels and blocking voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Acts as a competitive prolyl-tRNA synthetase inhibitor.
- Inhibits type-I collagen synthesis.
- Attenuates osteoarthritis by inhibiting TGF-β activity.
- Functions as a potent pulmonary vasodilator.
- Activates Kv channels.
- Blocks voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Possesses anti-malaria effects.
- Demonstrates anti-inflammatory properties.
- Exhibits anti-cancer and anti-fibrosis effects.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Pifithrin-β hydrobromide | 511296-88-1 | 99.9% | 349.29 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Pifithrin-β hydrobromide is a potent p53 inhibitor with an IC50 of 23 μM. It is regarded as a lead compound for cancer and neurodegenerative disease therapy. Pifithrin-α, an inhibitor of the p53 protein, is unstable in culture medium and quickly converts to pifithrin-β. Studies show that pretreatments with 1 and 10 μM pifithrin-β can exert neuroprotective effects after 24 hours.
- Potent p53 inhibitor with an IC50 of 23 μM.
- Regarded as a lead compound for cancer and neurodegenerative disease therapy.
- Exerts neuroprotective effects.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Halofuginone hydrobromide (RU-19110) is a Febrifugine derivative that acts as a competitive prolyl-tRNA synthetase inhibitor. It is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibiting TGF-β activity. This compound exhibits various biological effects, including anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis activities. It also functions as a potent pulmonary vasodilator.
- Competitive prolyl-tRNA synthetase inhibitor.
- Inhibits type-I collagen synthesis.
- Attenuates osteoarthritis by inhibiting TGF-β activity.
- Potent pulmonary vasodilator, activating Kv channels and blocking Ca2+ channels.
- Exhibits anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis effects.
- Decreases NRF2 protein levels in tumors.
- Partially reverses established pulmonary hypertension.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 62595-74-8 | 3-bromopiperidine-2,6-dione | Pharmablock | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 250g | 812209008
3-bromopiperidine-2,6-dione | Pharmablock | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 250g | 812209008
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Nan-190 hydrobromide | 115338-32-4 | 99.1% | 474.39 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NAN-190 hydrobromide is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A.
- Serotonin receptor 5-HT antagonist
- Selective antagonist of 5-HT1A
- IC50 & Target: 5-HT1A Receptor, 5-HT1 Receptor
- Reverses the catalepsy-improving effect of fluoxetine in 6-OHDA lesioned rats when injected at 0.5 mg/kg (ip) concomitantly with fluoxetine
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Eletriptan hydrobromide | 177834-92-3 | 99.8% | C22H27BrN2O2S | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Eletriptan hydrobromide (Eletriptan HBr) is a 5-HT1B and 5-HT1D receptor agonist with antimigraine activity. It has Ki values of 0.92 nM for 5-HT1B receptors and 3.14 nM for 5-HT1D receptors.
- Dose-dependently reduces carotid blood flow in anesthetized dogs (1-1000 μg/kg; i.v.)
- Inhibits dural plasma protein extravasation in anesthetized rats (30-300 μg/kg; i.v.)
- Completely inhibits extravasation from the dura mater at 100 μg/kg
- Appears as an off-white to light brown solid
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Eletriptan hydrobromide | 177834-92-3 | 99.8% | C22H27BrN2O2S | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Eletriptan hydrobromide (Eletriptan HBr) is a 5-HT1B and 5-HT1D receptor agonist with antimigraine activity, with Ki values of 0.92 nM and 3.14 nM, respectively. It is for research use only and not sold to patients.
- 5-HT1B and 5-HT1D receptor agonist
- Antimigraine activity
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC SCH-202676 hydrobromide | 265980-25-4 | 96.8% | 348.26 g·mol⁻¹ | C15H14BrN3S | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
SCH-202676 hydrobromide is a small-molecule allosteric modulator of G protein-coupled receptors and adenosine receptors with reported antiviral activity, including inhibition of 3CLpro. The compound is supplied for research use in solid and solution forms and is intended for biochemical and pharmacological studies.
- Allosteric modulator of GPCRs and adenosine receptors.
- Reported antiviral activity; inhibits 3CLpro with low-micromolar potency.
- Available as solid and 10 mM solution in DMSO.
- High purity (96.81%).
- Molecular formula C15H14BrN3S; molecular weight 348.26 g·mol⁻¹.
- Store at -20°C long term; in solvent store at -80°C for extended stability.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC SCH-202676 (hydrobromide) | 265980-25-4 | 96.8% | 348.26 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
SCH-202676 hydrobromide is an allosteric modulator of G protein-coupled receptors (GPCRs) and adenosine receptor (AR). It demonstrates antiviral activity and inhibits 3CLpro in a time-dependent manner with an IC50 value of 0.655 μM.
- Purity: 96.81%
- Appearance: Solid
- Color: White to off-white
- Solubility: DMSO: 10 mg/mL
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More